Your browser doesn't support javascript.
loading
Immunogenicity and safety of third-dose mRNA COVID-19 vaccines in healthy adults previously vaccinated with two doses of the ChAdOx1 vaccine.
Sheng, Wang-Huei; Ieong, Si-Man; Lin, Pin-Hung; Hsieh, Ming-Ju; Yang, Hung-Chih; Pan, Ching-Fu; Chao, Tai-Ling; Chang, Sui-Yuan; Chang, Shan-Chwen.
Afiliación
  • Sheng WH; Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; School of Medicine, National Taiwan University College of Medicine, Taipei City, Taiwan.
  • Ieong SM; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Lin PH; Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Hsieh MJ; Department of Emergency Medicine, National Taiwan University Hospital, Taipei, Taiwan; Occupational Safety and Health Office, National Taiwan University Hospital, Taipei, Taiwan.
  • Yang HC; Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Pan CF; Graduate Institute of Microbiology, College of Medicine, National Taiwan University, Taipei, Taiwan.
  • Chao TL; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
  • Chang SY; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei City, Taiwan.
  • Chang SC; Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan; School of Medicine, National Taiwan University College of Medicine, Taipei City, Taiwan. Electronic address: changsc@ntu.edu.tw.
J Formos Med Assoc ; 122(2): 121-131, 2023 Feb.
Article en En | MEDLINE | ID: mdl-36127206

Texto completo: 1 Colección: 01-internacional Asunto principal: Vacunas Virales / Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: J Formos Med Assoc Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Colección: 01-internacional Asunto principal: Vacunas Virales / Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: J Formos Med Assoc Asunto de la revista: MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Taiwán